PPT-Pulmonary CSI: Following the Evidence

Dr Kimberly Clark Clinical Associate Professor MSRC Program Director Department of Kinesiology Conflict of Interest Disclosure I have no real or perceived conflicts of interest in providing this presentation. PGYV PULMONARY FELLOW. FINANCIAL DISCLOSURES. None. OBJECTIVES. Learn to define the disorder. Classification and prevalence. Pathophysiology and histopathology. Presentation. Screening and diagnostic methods. PULMONARY EDEMA. 1. LECTURE NOTES BY:. Dr. . Syed Mohammad Zub. air. MBBS(KE) BS (PU) DHA (CCM) FWHO(UK) MBA;FACHE (US) M.PHIL (PHYSIOLOGY). Assist. Prof Physiology . KING EDWARD . MEDICAL. UNIVERSITY, Lahore.. Rajan Joshi MD,FCCP, FAASM. Assistant Professor, Pulmonary Critical care, Sleep Medicine at UKHC. Medical Director, Pulmonary Rehabilitation, UKHC, Lexington. KY. TLC & Sleep Center-PR, Richmond, KY. . Dr. . K.J.Priyadarshini. . Gandhi Medical College. Case Details…. 24 year old . Mr.X. D. river by occupation . N. on diabetic, . denovo. detected hypertensive. CASE PRESENTATIONCASE PRESENTATIONMrs N Mkhize 51 yr old presented withMrs N Mkhize 51 yr old presented with--Shortness of breath for one days durationShortness of breath for one days durationRisk fac Diagnostic Radiology elective. SK, 69 . y.o. . F. Initially admitted . with . heavy vaginal bleeding and severe . anemia. Transfused, started on . Megace. (. megestrol. ). 5 cm mass on TVUS, grade 1 . . Contributed by: . Hillary Cooper, M.A., CCC-SLP. &. Jessica Hill, M.S., CCC-SLP. www.medslpcollective.com. History of Thickener Use. Thickener use has historically been widely considered to be a benign intervention for dysphagia..      Providing Continuing Education for Healthcare Professionals.      Provided by ProCE, LLC and supported by an educational grant. from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson.. Deep Vein Thrombosis. By. SCENARIO:. Here is a 46 years old female patient admitted in surgery department and diagnosed as Acute pulmonary embolism with DVT and hospitalized for 7 days.. CHIEF COMPLAINTS: c/o chest pain since 3days.. F. unction. The MESA Lung Study. R Graham Barr, MD . DrPH. Departments of Medicine and Epidemiology. Columbia University Medical Center. Funding: NHLBI . R01s HL077612. ,. HL075476. ,. HL093081. RC1 . Restrictive diseases could be scored by similar categories asthe GOLD guidelines (mild, moderate, severe, very severe) based on percent FVC and could be subject to the same driving restrictions when h DR. NISHI. Assistant Professor. Department of Pathology. SKMCH, . Muzaffarpur. Pulmonary Diseases . of Vascular Origin. Pulmonary Embolism and Infarction. Pulmonary Hypertension. Diffuse Pulmonary . Hemorrhage. Khaled Al Oweidat, MD. PE. Introduction . Partial or complete occlusion of a pulmonary arterial branch by blood clot(thrombus or multiple thrombi).. Deep vein thrombosis and PE are different presentations of the same underlying pathophysiological event, venous thromboembolism (VTE).. 02/01/2021. RAD 4001. Clinical History. 83 yo male. PMHx CAD s/p PCI x3 (8-10 . yr. ago) and CVA w/ residual blindness. Presented after LOC and complaining of a five day hx of chest pain. Bilateral painful leg swelling 3 days ago that resolved after 24 hours.